{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:11:10Z","timestamp":1790683870441,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd009444.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T00:00:00Z","timestamp":1425340800000}}],"reference-count":54,"publisher":"Wiley","issue":"3","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009444.pub3","type":"journal-article","created":{"date-parts":[[2015,3,3]],"date-time":"2015-03-03T16:13:20Z","timestamp":1425399200000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Cholinesterase inhibitors for rarer dementias associated with neurological conditions"],"prefix":"10.1002","volume":"2015","author":[{"given":"Ying","family":"Li","sequence":"first","affiliation":[{"name":"West China Hospital, Sichuan University; Center of Geriatrics and Gerontology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Hai","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Center of Geriatrics and Gerontology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhou","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Center of Geriatrics and Gerontology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi Rong","family":"Dong","sequence":"additional","affiliation":[{"name":"West China Hospital, Sichuan University; Center of Geriatrics and Gerontology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,3,3]]},"reference":[{"issue":"7","key":"10.1002\/14651858.CD009444.pub3-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1212\/01.wnl.0000238106.10423.00","article-title":"Effect of donepezil on motor and cognitive function in Huntington disease","volume":"67","author":"Cubo","year":"2006","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009444.pub3-BIB0002|cit2","doi-asserted-by":"crossref","unstructured":"Dichgans M Markus HS Salloway S Verkkoniemi A Moline M Wang Q Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL Lancet Neurology 2008 310 8","DOI":"10.1016\/S1474-4422(08)70046-2"},{"key":"10.1002\/14651858.CD009444.pub3-BIB0003|cit3","doi-asserted-by":"crossref","unstructured":"Kertesz A Morlog D Light M Blair M Davidson W Jesso S Galantamine in frontotemporal dementia and primary progressive aphasia Dementia and Geriatric Cognitive Disorders 2008 178 85","DOI":"10.1159\/000113034"},{"key":"10.1002\/14651858.CD009444.pub3-BIB0004|cit4","doi-asserted-by":"crossref","unstructured":"Krupp LB Christodoulou C Melville P Scherl WF MacAllister WS Elkins LE Donepezil improved memory in multiple sclerosis in a randomized clinical trial Neurology 2004 1579 85","DOI":"10.1212\/01.WNL.0000142989.09633.5A"},{"key":"10.1002\/14651858.CD009444.pub3-BIB0005|cit5","doi-asserted-by":"crossref","unstructured":"Krupp LB Christodoulou C Melville P Scherl WF Pai L-Y Muenz LR Multicenter randomized clinical trial of donepezil for memory impairment in multiple sclerosis Neurology 2011 1500 7","DOI":"10.1212\/WNL.0b013e318218107a"},{"key":"10.1002\/14651858.CD009444.pub3-BIB0006|cit6","doi-asserted-by":"crossref","unstructured":"Maurer M Ortler S Baier M Meergans M Scherer P Hofmann W Randomised multicentre trial on safety and efficacy of rivastigmine in cognitively impaired multiple sclerosis patients Multiple Sclerosis 2013 631 8","DOI":"10.1177\/1352458512463481"},{"issue":"3","key":"10.1002\/14651858.CD009444.pub3-BIB0007|cit7","first-page":"239","article-title":"Cognitive function in early clinical phase huntington disease after rivastigmine treatment","volume":"26","author":"Se\u0161ok","year":"2014","journal-title":"Psychiatria Danubina"},{"key":"10.1002\/14651858.CD009444.pub3-BIB0008|cit8","doi-asserted-by":"crossref","unstructured":"Shaygannejad V Janghorbani M Ashtari F Zanjani HA Zakizade N Effects of rivastigmine on memory and cognition in multiple sclerosis Canadian Journal of Neurological Sciences 2008 476 81","DOI":"10.1017\/S0317167100009148"},{"issue":"12","key":"10.1002\/14651858.CD009444.pub3-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1002\/mds.20235","article-title":"Effects of rivastigmine on motor and cognitive impairment in Huntington's disease","volume":"19","author":"Tommaso","year":"2004","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1002\/14651858.CD009444.pub3-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/01.wnf.0000240945.44370.f0","article-title":"Two years' follow-up of rivastigmine treatment in Huntington disease","volume":"30","author":"Tommaso","year":"2007","journal-title":"Clinical Neuropharmacology"},{"issue":"2","key":"10.1002\/14651858.CD009444.pub3-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1034\/j.1600-0404.2001.103002123.x","article-title":"Donepezil in the treatment of progressive supranuclear palsy","volume":"103","author":"Fabbrini","year":"2001","journal-title":"Acta Neurologica Scandinavica"},{"issue":"3","key":"10.1002\/14651858.CD009444.pub3-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/00004714-200006000-00010","article-title":"A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments","volume":"20","author":"Greene","year":"2000","journal-title":"Journal of clinical psychopharmacology"},{"key":"10.1002\/14651858.CD009444.pub3-BIB0013|cit13","doi-asserted-by":"crossref","unstructured":"Litvan I Phipps M Pharr VL Hallett M Grafman J Salazar A Randomized placebo-controlled trial of donepezil in patients with progressive supranuclear palsy Neurology 2001 467 73","DOI":"10.1212\/WNL.57.3.467"},{"issue":"14","key":"10.1002\/14651858.CD009444.pub3-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2165\/00002512-200421140-00003","article-title":"Rivastigmine in frontotemporal dementia: an open-label study","volume":"21","author":"Moretti","year":"2004","journal-title":"Drugs & aging"},{"issue":"11","key":"10.1002\/14651858.CD009444.pub3-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.exger.2012.07.002","article-title":"Pharmacological prevention and treatment of vascular dementia: approaches and perspectives","volume":"47","author":"Baskys","year":"2012","journal-title":"Experimental Gerontology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009444.pub3-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"S192","DOI":"10.1016\/S1353-8020(11)70060-8","article-title":"Progressive supranuclear palsy","volume":"18","author":"Boeve","year":"2012","journal-title":"Parkinsonism Related Disorders"},{"issue":"4","key":"10.1002\/14651858.CD009444.pub3-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1136\/jnnp.57.4.416","article-title":"Clinical and neuropathological criteria for frontotemporal dementia","volume":"57","author":"Brun","year":"1994","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD009444.pub3-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00406-007-1006-x","article-title":"Pharmacogenomics and therapeutic prospects in dementia","volume":"258","author":"Cacabelos","year":"2008","journal-title":"European Archives of Psychiatry and Clinical Neuroscience"},{"issue":"12","key":"10.1002\/14651858.CD009444.pub3-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/S1474-4422(08)70259-X","article-title":"Cognitive impairment in multiple sclerosis","volume":"7","author":"Chiaravalloti","year":"2008","journal-title":"Lancet Neurology"},{"issue":"1","key":"10.1002\/14651858.CD009444.pub3-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3988\/jcn.2010.6.1.1","article-title":"Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: a genetic cause of cerebral small vessel disease","volume":"6","author":"Choi","year":"2010","journal-title":"Journal of Clinical Neurology (Seoul, Korea)"},{"key":"10.1002\/14651858.CD009444.pub3-BIB0021|cit21","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD009444.pub3-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jstrokecerebrovasdis.2010.11.008","article-title":"Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL): from discovery to gene identification","volume":"20","author":"Fukutake","year":"2011","journal-title":"Journal of Stroke and Cerebrovascular Diseases"},{"issue":"2","key":"10.1002\/14651858.CD009444.pub3-BIB0023|cit23","first-page":"211","article-title":"Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer's disease: a systematic review and meta-analysis","volume":"3","author":"Hansen","year":"2008","journal-title":"Clinical interventions in Aging"},{"key":"10.1002\/14651858.CD009444.pub3-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistencies in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD009444.pub3-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000321712","article-title":"A systematic review of the incidence and prevalence of long-term neurological conditions in the UK","volume":"36","author":"Hoppitt","year":"2011","journal-title":"Neuroepidemiology"},{"issue":"6602","key":"10.1002\/14651858.CD009444.pub3-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/383707a0","article-title":"Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia","volume":"383","author":"Joutel","year":"1996","journal-title":"Nature"},{"issue":"1","key":"10.1002\/14651858.CD009444.pub3-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/01.STR.0000251787.90695.05","article-title":"Cholinergic neuronal deficits in CADASIL","volume":"38","author":"Keverne","year":"2007","journal-title":"Stroke"},{"issue":"5","key":"10.1002\/14651858.CD009444.pub3-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1742-1241.2009.02052.x","article-title":"Pharmacokinetics of a novel transdermal rivastigmine patch for the treatment of Alzheimer's disease: a review","volume":"63","author":"Kurz","year":"2009","journal-title":"International journal of clinical practice"},{"issue":"3","key":"10.1002\/14651858.CD009444.pub3-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/1756285609102724","article-title":"Therapy for Alzheimer's Disease: How effective are current treatments?","volume":"2","author":"Lanct\u00f4t","year":"2009","journal-title":"Therapeutic Advances in Neurological Disorders"},{"issue":"3","key":"10.1002\/14651858.CD009444.pub3-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s13311-011-0047-z","article-title":"Vascular cognitive impairment: disease mechanisms and therapeutic implications","volume":"8","author":"Levine","year":"2011","journal-title":"Neurotherapeutics"},{"issue":"3","key":"10.1002\/14651858.CD009444.pub3-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/mds.22987","article-title":"Incidence of Parkinson's disease and parkinsonism in northern Sweden: a population-based study","volume":"25","author":"Linder","year":"2010","journal-title":"Movement Disorders"},{"issue":"1","key":"10.1002\/14651858.CD009444.pub3-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009444.pub3-BIB0033|cit33","unstructured":"Martin P Ma\u00eblenn G Matthew P Alzheimer\u2019s Disease International Policy Brief for Heads of Government: The Global Impact of Dementia 2013-2050 http:\/\/www.alz.co.uk\/research\/GlobalImpactDementia2013.pdf December 2013"},{"issue":"7","key":"10.1002\/14651858.CD009444.pub3-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1212\/01.WNL.0000055927.22611.EB","article-title":"Cholinergic denervation in a pure multi-infarct state: observations on CADASIL","volume":"60","author":"Mesulam","year":"2003","journal-title":"Neurology"},{"issue":"39","key":"10.1002\/14651858.CD009444.pub3-BIB0035|cit35","first-page":"684","article-title":"Lewy body and parkinsonian dementia: common, but often misdiagnosed conditions","volume":"107","author":"Mollenhauer","year":"2010","journal-title":"Deutsches \u00c4rzteblatt International"},{"issue":"13","key":"10.1002\/14651858.CD009444.pub3-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1212\/WNL.0b013e31824d586c","article-title":"The minimum prevalence of CADASIL in northeast England","volume":"78","author":"Narayan","year":"2012","journal-title":"Neurology"},{"issue":"6","key":"10.1002\/14651858.CD009444.pub3-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1212\/WNL.51.6.1546","article-title":"Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria","volume":"51","author":"Neary","year":"1998","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD009444.pub3-BIB0038|cit38","volume-title":"Donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease.","author":"National Institute for Health and Clinical Excellence (NICE)","year":"2011"},{"issue":"9","key":"10.1002\/14651858.CD009444.pub3-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1017\/S104161021200035X","article-title":"Caregivers of patients with frontotemporal lobar degeneration: a review of burden, problems, needs, and interventions","volume":"24","author":"Nunnemann","year":"2012","journal-title":"International Psychogeriatrics\/IPA"},{"issue":"7","key":"10.1002\/14651858.CD009444.pub3-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/jnnp.74.7.965","article-title":"Alterations of muscarinic acetylcholine receptors in atypical Pick's disease without Pick bodies","volume":"74","author":"Odawara","year":"2003","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD009444.pub3-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11910-011-0215-x","article-title":"Cognitive impairment in Huntington disease: diagnosis and treatment","volume":"11","author":"Paulsen","year":"2011","journal-title":"Current Neurology and Neuroscience Reports"},{"issue":"2","key":"10.1002\/14651858.CD009444.pub3-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1002\/14651858.CD009444.pub3-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","article-title":"New diagnostic criteria for multiple sclerosis: guidelines for research protocols","volume":"13","author":"Poser","year":"1983","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD009444.pub3-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/978-1-4614-0653-2_9","article-title":"Frontotemporal Lobar Degeneration","volume":"724","author":"Premi","year":"2012","journal-title":"Advances in Experimental Medicine and Biology"},{"issue":"9","key":"10.1002\/14651858.CD009444.pub3-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/mds.25075","article-title":"The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis","volume":"27","author":"Pringsheim","year":"2012","journal-title":"Movement Disorders"},{"issue":"5","key":"10.1002\/14651858.CD009444.pub3-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2165\/11533100-000000000-00000","article-title":"Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management","volume":"24","author":"Rabinovici","year":"2010","journal-title":"CNS Drugs"},{"key":"10.1002\/14651858.CD009444.pub3-BIB0047|cit47","unstructured":"Rahn K Slusher B Kaplin A Cognitive impairment in Multiple Sclerosis: a forgotten disability remembered Cerebrum 2012 Nov [Epub ahead of print]"},{"issue":"Pt 9","key":"10.1002\/14651858.CD009444.pub3-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"issue":"5","key":"10.1002\/14651858.CD009444.pub3-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1136\/jnnp.2004.051847","article-title":"The prevalence of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL) in the west of Scotland","volume":"76","author":"Razvi","year":"2005","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD009444.pub3-BIB0050|cit50","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006504.pub2","article-title":"Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease","author":"Rolinski","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD009444.pub3-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1136\/jnnp.50.5.538","article-title":"Acetylcholinesterase and butyrylcholinesterase activity in the cerebrospinal fluid of patients with neurodegenerative diseases involving cholinergic systems","volume":"50","author":"Ruberg","year":"1987","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD009444.pub3-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pharmthera.2011.12.002","article-title":"Pharmacotherapies for Alzheimer's disease: beyond cholinesterase inhibitors","volume":"134","author":"Tayeb","year":"2012","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1002\/14651858.CD009444.pub3-BIB0053|cit53","volume-title":"International Statistical Classification of Diseases and Related Health Problems 10th Revision Version (ICD-10)","author":"World Health Organization","year":"2010"},{"issue":"8980","key":"10.1002\/14651858.CD009444.pub3-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/S0140-6736(95)91557-5","article-title":"Clinical spectrum of CADASIL: a study of 7 families. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy","volume":"346","author":"Chabriat","year":"1995","journal-title":"Lancet"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD009444.pub3\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T17:32:06Z","timestamp":1699983126000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009444.pub3"}},"subtitle":[],"editor":[{"name":"Cochrane Dementia and Cognitive Improvement Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,3,3]]},"references-count":54,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2015,3]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009444.pub3","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,3]]}}}